Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: early results of an international phase III study.

K Mattson,R Abratt,G.Velde Ten,K Krofta,D Tonelli,I Avril;K Mattson;R Abratt;G.Velde Ten;K Krofta;D Tonelli;I Avril;

lung cancer (amsterdam, netherlands) 2001 Vol. 34 pp. 21-23

258

avril2001lungdocetaxel

lung cancer docetaxel adjuvant therapy neo adjuvant international phase treatable stage radically treatable

DOI:

URL:

ID: 272161

Ref Key: avril2001lungdocetaxel

Use this key to autocite in SciMatic or Thesis Manager

No Bibliography

Account:

NFT Contract Address:

0x95644003c57E6F55A65596E3D9Eac6813e3566dA

Article ID:

272161

Unique Identifier:

10.1016/s0169-5002(01)00389-0

Network:

Scimatic Chain (ID: 481)

Authors

Abstract

Journal Name

Year

Title

4/5

Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Gas fees required in SCI Coins

Coming soon

Reference Key: lastname+year+titlefirstword+journalfirstword

Article Type (Article, Book, Proceedings etc.)

Add a reference in a raw form. Our automatic system will correct it later.